COVID-19 in chronic myeloid leukemia patients in Latin America.

Autor: Pagnano KB; Hematology and Hemotherapy Center, University of Campinas, Campinas, SP, Brazil., Peralta EH; Hospital Nacional Edgardo Rebagliati Martins, Jesús María, Peru., Navarro JR; Hospital Nacional Edgardo Rebagliati Martins, Jesús María, Peru., David Salas LDR; Hospital Nacional Edgardo Rebagliati Martins, Jesús María, Peru., Delgado N; Centro Médico Nacional Siglo XXI IMSS, Cuauhtémoc, México Ciudad de México., Moiraghi B; JM Ramos Mejia CABA, Buenos Aires, Argentina., Toreli ACM; Hospital de Transplantes Euryclides de Jesus Zerbini, São Paulo, Brazil., Perobelli LM; Hospital de Transplantes Euryclides de Jesus Zerbini, São Paulo, Brazil., Fechio L; Hematology and Hemotherapy Center, University of Campinas, Campinas, SP, Brazil., Quixada ATS; Faculdade de Medicina da Universidade Federal do Ceará, Hospital Universitário Walter Cantídio, Fortaleza, Brazil., Funke V; Complexo Hospital de Clínicas - Universidade Federal do Paraná, Curitiba, Brazil., Bendit I; Laboratory of Medical Investigation in Pathogenesis and targeted therapy in Onco-Immuno-Hematology (LIM/31), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Seguro FS; Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil., Pilleux L; Hospital de Valdivia, Bueras, Los Ríos, Chile., Bortolini J; Centro de Pesquisas Oncológicas, Florianópolis, Brazil., Lourenço ALG; Hospital dos Fornecedores de Cana de Piracicaba, Piracicaba, Brazil., Sapelli J; Hospital AC Camargo Cancer Center, São Paulo, Brazil., Nucci FM; Hospital Universitário Antonio Pedro, Universidade Federal Fluminense, Niterói, Brazil., Pavlovsky C; Hospitalization & Clinical Research Center, Fundaleu, CABA, Argentina., Oliveira LDC; Hospital Jorge Valente, Salvador, Brazil., Moura MS; Hospital Santa Casa de Misericordia de Maceió, Maceió, Brazil., Palma LC; Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil., Gonçalves NN; Hospital Santa Marcelina, São Paulo, Brazil., Conchon M; Hospital Santa Marcelina, São Paulo, Brazil., Hokama POM; São Paulo State University, UNESP, Medical School, Campus de Botucatu, Botucatu, Brazil., Almeida LL; São Paulo State University, UNESP, Medical School, Campus de Botucatu, Botucatu, Brazil., Zulli R; Hematology and Hemotherapy Center, University of Campinas, Campinas, SP, Brazil., de Souza CA; Hematology and Hemotherapy Center, University of Campinas, Campinas, SP, Brazil., Boquimpani CM; Hemorio, Rio de Janeiro, Brazil.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2021 Dec; Vol. 62 (13), pp. 3212-3218. Date of Electronic Publication: 2021 Jul 13.

BuCyE can safely replace BEAM as a conditioning regimen for autologous stem cell transplantation in the treatment of refractory and relapsed lymphomas.

Autor: Sapelli J; Department of Hematology, Department of Bone Marrow Transplantation, AC Camargo Cancer Center, São Paulo, Brazil. Electronic address: jaqueline.sapelli@accamargo.org.br., Filho JS; Department of Hematology, Department of Bone Marrow Transplantation, AC Camargo Cancer Center, São Paulo, Brazil., Matias Vieira GM; Department of Hematology, Grupo Oncoclinicas, São Paulo, Brazil., Moura FL; Department of Hematology, Department of Bone Marrow Transplantation, AC Camargo Cancer Center, São Paulo, Brazil., Germano JN; Department of Statistics, AC Camargo Cancer Center, São Paulo, Brazil., de Lima VCC; Department of Clinical Oncology, Oncologia D'Or/Intituto do Cancer do estado de São Paulo, São Paulo, Brazil.

Publikováno v: Leukemia research [Leuk Res] 2021 Nov; Vol. 110, pp. 106689. Date of Electronic Publication: 2021 Sep 15.

MANIFESTAÇÕES ORAIS DA LEUCEMIA MIELOIDE AGUDA COMO PRIMEIROS SINAIS E SINTOMAS DA DOENÇA: RELATO DE CASO E IMPORTÂNCIA DO CIRURGIÃO-DENTISTA NO DIAGNÓSTICO PRECOCE

Autor: Silva, C.R.C.C., Oliveira, D.M.H., Castro, M.S., Nóbrega, K.H.S., Carvalho, G.L., Lima, M.H.A., Prado, J.D., Sapelli, J., Costa, F.D., Araujo, J.P.

Publikováno v: In Hematology, Transfusion and Cell Therapy November 2020 42 Supplement 2:470-470

Evaluation of busulfan, cyclophosphamide, and etoposide as a preparation regimen for autologous stem cell transplantation in Hodgkin's lymphoma patients.

Autor: Biçim, Soykan¹, Erkurt, Mehmet Ali¹ erkurtali@hotmail.com, Kuku, İrfan¹, Kaya, Emin¹, Berber, İlhami¹, Kaya, Ahmet¹, Hidayet, Emine², Uysal, Ayşe³, Sarıcı, Ahmet⁴, Özen, İlknur Nizam⁵

Publikováno v: Iraqi Journal of Hematology. Jan-Jun2024, Vol. 13 Issue 1, p1-6. 6p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.